Innate immune regulation of adaptive immunity: mechanisms, implications, and bias - Report - MDSpire

Innate immune regulation of adaptive immunity: mechanisms, implications, and bias

  • By

  • Yikai Zhang

  • Yuao Qin

  • Zekun Cheng

  • May 28, 2026

  • 0 min

Share

Clinical Report: Regulation of Adaptive Immunity by Innate Immune Mechanisms

Overview

This review discusses the role of innate immunity in regulating adaptive immune responses, including mechanisms such as antigen presentation and cytokine production.

Background

This review addresses the interplay between innate and adaptive immunity in immune-mediated diseases.

Data Highlights

No numerical or trial data available in the source material.

Key Findings

  • Innate immunity regulates adaptive immune fate through various mechanisms, including cytokine production and antigen presentation.
  • Defective signaling in innate immunity can impair pathogen control and adaptive immune priming.
  • Persistent activation of innate immune pathways may lead to autoimmune inflammation and loss of tolerance.
  • Type 2-biased epithelial signaling contributes to allergic inflammation via the alarmin–ILC2–Th2–IgE axis.
  • Trained immunity results in long-lasting changes in innate immune cells, affecting later adaptive responses.

Clinical Implications

The findings suggest that targeting innate immune pathways may provide therapeutic opportunities for managing autoimmune and allergic diseases. Understanding the mechanisms of innate regulation can help in developing strategies to restore immune balance.

Conclusion

This review underscores the importance of innate immunity in shaping adaptive immune responses and highlights potential areas for therapeutic intervention.

Related Resources & Content

  1. Frontiers in Immunology, 2026 -- Editorial: The role of innate immunity in the pathogenesis of autoimmune and autoinflammatory diseases
  2. Frontiers in Immunology, 2026 -- Editorial: Exploring immunological tolerance in allergy treatment through AIT
  3. Intensive Care Medicine -- An Introduction to Targeted Immunomodulation for Critical Care Physicians
  4. Frontiers in Immunology, 2026 -- Regulatory T cell therapy in autoimmune and immune-mediated diseases: from basic research to clinical practice and future perspectives
  5. ACIP Recommendations Summary | Influenza (Flu) | CDC
  6. Efficacy, safety, and immunogenicity of the AS01E-adjuvanted respiratory syncytial virus prefusion F protein vaccine (RSVPreF3 OA) in older adults over three respiratory syncytial virus seasons (AReSVi-006): a multicentre, randomised, observer-blinded, placebo-controlled, phase 3 trial - ScienceDirect
  7. ACIP Recommendations Summary | Influenza (Flu) | CDC
  8. Efficacy, safety, and immunogenicity of the AS01E-adjuvanted respiratory syncytial virus prefusion F protein vaccine (RSVPreF3 OA) in older adults over three respiratory syncytial virus seasons (AReSVi-006): a multicentre, randomised, observer-blinded, placebo-controlled, phase 3 trial - ScienceDirect
  9. AREXVY | FDA

Original Source(s)

Related Content